Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
129.12
-0.91 (-0.70%)
At close: Oct 13, 2025, 4:00 PM EDT
129.00
-0.12 (-0.09%)
After-hours: Oct 13, 2025, 4:18 PM EDT
Novartis AG Stock Forecast
Stock Price Forecast
The 2 analysts that cover Novartis AG stock have a consensus rating of "Sell" and an average price target of $119, which forecasts a -7.84% decrease in the stock price over the next year. The lowest target is $118 and the highest is $120.
Price Target: $119 (-7.84%)
Analyst Consensus: Sell
* Price targets were last updated on Sep 12, 2025.
Analyst Ratings
The average analyst rating for Novartis AG stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 6 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 6 | 6 | 6 | 6 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $119 → $118 | Hold → Strong Sell | Downgrades | $119 → $118 | -8.61% | Sep 12, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 13, 2025 |
| Erste Group | Erste Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 19, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $118 → $120 | Hold | Maintains | $118 → $120 | -7.06% | Oct 30, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $135 → $130 | Strong Buy → Hold | Downgrades | $135 → $130 | +0.68% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
56.41B
from 51.72B
Increased by 9.06%
Revenue Next Year
57.84B
from 56.41B
Increased by 2.54%
EPS This Year
9.07
from 5.87
Increased by 54.58%
EPS Next Year
9.44
from 9.07
Increased by 4.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 60.9B | 63.7B | |||
| Avg | 56.4B | 57.8B | |||
| Low | 51.7B | 53.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.7% | 12.9% | |||
| Avg | 9.1% | 2.5% | |||
| Low | -0.1% | -5.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.70 | 10.92 | |||
| Avg | 9.07 | 9.44 | |||
| Low | 8.13 | 7.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 65.3% | 20.3% | |||
| Avg | 54.6% | 4.0% | |||
| Low | 38.6% | -12.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.